ENTRY       D11756                      Drug
NAME        Fletikumab (USAN/INN)
FORMULA     C6494H10000N1728O2050S44
EXACT_MASS  146399.9083
MOL_WEIGHT  146490.0934
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKRPGASVKV SCKASGYTFT NDIIHWVRQA PGQRLEWMGW INAGYGNTQY
            SQNFQDRVSI TRDTSASTAY MELISLRSED TAVYYCAREP LWFGESSPHD YYGMDVWGQG
            TTVTVSSAST KGPSVFPLAP CSRSTSESTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF
            PAVLQSSGLY SLSSVVTVPS SSLGTKTYTC NVDHKPSNTK VDKRVESKYG PPCPPCPAPE
            FLGGPSVFLF PPKPKDTLMI SRTPEVTCVV VDVSQEDPEV QFNWYVDGVE VHNAKTKPRE
            EQFNSTYRVV SVLTVLHQDW LNGKEYKCKV SNKGLPSSIE KTISKAKGQP REPQVYTLPP
            SQEEMTKNQV SLTCLVKGFY PSDIAVEWES NGQPENNYKT TPPVLDSDGS FFLYSRLTVD
            KSRWQEGNVF SCSVMHEALH NHYTQKSLSL SLGK
            (Light chain)
            AIQLTQSPSS LSASVGDRVT ITCRASQGIS SALAWYQQKP GKAPKLLIYD ASSLESGVPS
            RFSGSGSGTD FTLTISSLQP EDFATYYCQQ FNSYPLTFGG GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H141-L214, H154-H210, H233-H'233, H236-H'236, H268-H328, H374-H432, H'22-H'96, H'141-L'214, H'154-H'210 H'268-H'328, H'374-H'432, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
EFFICACY    Antirheumatic, Anti-IL-20 antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of rheumatoid arthritis
TARGET      IL20 [HSA:50604] [KO:K22667]
  PATHWAY   hsa04060(50604)  Cytokine-cytokine receptor interaction
            hsa04630(50604)  JAK-STAT signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Interleukins
                IL20
                 D11756  Fletikumab (USAN/INN)
DBLINKS     CAS: 1357158-22-5
            PubChem: 405226622
///
